Preso

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Preso

What is Preso? (Esomeprazole)

Property Description
Active Ingredient Esomeprazole
Form Delayed-release capsule/tablet, oral powder, injection
Pharmacological Class Proton Pump Inhibitor (PPI)
General Purpose Gastric acid suppression
Origin Synthetic substituted benzimidazole

What Type of Medicine is Preso? Identity and Class

Preso is a synthetic pharmaceutical preparation that contains the active ingredient Esomeprazole, a compound derived from the substituted benzimidazole class. It is classified as a Proton Pump Inhibitor (PPI), a specialized group of medicines engineered to control and reduce the production of acid in the stomach. These agents are utilized for achieving effective gastric acid suppression. Esomeprazole itself is structurally significant as the isolated S-isomer—the pharmacologically active component—of the related drug omeprazole. This unique structural differentiation is clinically recognized for providing a consistent profile of acid control compared to the racemic mixture.


Preso Composition and Available Forms

The key substance responsible for Preso's effect is its sole active ingredient, Esomeprazole, typically presented as a salt, such as the magnesium or strontium form, which is a product of synthetic organic chemistry. For patient administration, Preso is supplied in several dosage forms, including delayed-release capsules and tablets, powder for oral suspension, and a lyophilized powder for intravenous injection. The oral forms utilize enteric-coated granules which are crucial: this specialized coating ensures the active ingredient is protected from degradation by stomach acid and can be consistently absorbed into the body. This specific coating mechanism is a differentiating factor that defines the product's stable oral bioavailability.


General Purpose: Why Does Preso Suppress Stomach Acid?

The general purpose of Preso is to achieve highly effective and sustained acid suppression in the stomach. This medicine acts by causing an irreversible inhibition of the proton pump mechanism, which is the final biological process responsible for secreting acid into the stomach. By maintaining a significantly reduced level of corrosive gastric acid, the medicine generally helps to alleviate irritation and pain in the upper digestive tract. This profound and sustained reduction in acid levels provides a biological basis for allowing tissue to heal naturally. This makes Preso typically relevant in scenarios where prolonged acid control is necessary to manage conditions like persistent heartburn or acid reflux.

What side effects are possible with Preso?

Possible Side Effects and Safety Information

The safety profile of Preso (Esomeprazole) is documented by regulatory bodies, classifying adverse reactions according to their frequency and the body system affected. These classifications distinguish between commonly reported reactions and those that are rare but clinically significant.

Frequency-Classified Adverse Reactions

Side effects are primarily categorized by the rate of their official documentation, based on clinical trials and post-marketing data:

  • Common: These include headache and various gastrointestinal disturbances, such as abdominal pain, constipation, diarrhea, flatulence, nausea, and vomiting. The regulatory label also notes fundic gland polyps (benign) are a common occurrence associated with long-term use.
  • Uncommon: Effects in this tier involve insomnia, dizziness, increased liver enzymes, dry mouth, and skin reactions (rash, pruritus).
  • Rare to Very Rare: Serious but infrequent reactions are documented across several system-organ classes, including blood disorders (e.g., agranulocytosis), hepatic failure, and severe dermatological reactions like Stevens-Johnson syndrome.

Safety Patterns and Constraints

The official prescribing information identifies specific risks associated with the duration of use. Long-term exposure (typically one year or more) is linked to an increased risk of bone fractures of the hip, wrist, or spine. Additionally, prolonged therapy is associated with the potential for hypomagnesemia (low serum magnesium), which can be severe.

Preso is contraindicated for individuals with known hypersensitivity to the active substance, other substituted benzimidazoles, or any component of the formulation. Regulatory documents also specify that caution is advised and dose adjustments may be necessary for patients with severe hepatic impairment.

Overdose and Emergency Response

Overdose Manifestations and Clinical Signs

Official regulatory guidance indicates that human experience with an acute Esomeprazole overdose is limited, but manifestations associated with high doses (such as those in excess of 240 mg per day) are typically transient. These reported symptoms primarily involve general gastrointestinal upset and a feeling of weakness. Regulatory documents also note that observations from acute toxicity studies include neurological signs such as tremor and ataxia, alongside changes in respiratory frequency. The clinical records specify that single doses of 80 mg have been reported as uneventful.


Emergency Actions and Required Management

Immediate medical intervention is required in all cases of suspected overdose. The official regulatory mandate is to contact a healthcare professional, hospital emergency department, or regional Poison Control Centre immediately, regardless of whether symptoms are currently present.

The standard management protocol is providing symptomatic and supportive care, as the labeling explicitly states that no specific antidote is known for Esomeprazole overdose. Furthermore, the drug's high plasma protein binding renders hemodialysis ineffective as a measure to reduce its concentration in the plasma, which informs the required supportive treatment approach.

Therapeutic Uses of Preso

Therapeutic Indications

Preso is a pharmacological treatment primarily utilized in the management of specific endocrine and metabolic conditions. Its primary function is to regulate hormonal balances that have been disrupted due to underlying health issues. By addressing these imbalances, the medication assists in stabilizing physiological processes that are essential for long-term health maintenance.

Principal Uses

The medication is most commonly prescribed for the following conditions:

  • Chronic Endocrine Management: It is used to supplement or replace specific hormones when the body is unable to produce them in sufficient quantities.
  • Metabolic Regulation: It helps in maintaining the appropriate levels of metabolic markers, ensuring that bodily systems function within their intended parameters.
  • Symptom Mitigation: In certain clinical contexts, it is used to alleviate the systemic effects associated with hormonal deficiencies.

Clinical Benefits

The therapeutic application of Preso is intended to provide several physiological benefits. These benefits focus on restoring systemic equilibrium and improving the patient’s overall metabolic profile.

Restoration of Hormonal Balance

The primary benefit of this treatment is the restoration of hormonal levels to a physiological range. This stabilization is critical for the proper functioning of various organ systems, including the cardiovascular and nervous systems. By maintaining these levels, the medication prevents the progression of symptoms associated with hormonal fluctuations.

Long-term Health Stabilization

Consistency in treatment helps in the long-term management of chronic conditions. By preventing the peaks and troughs of hormone levels, the medication contributes to a more predictable health status. This stability is a key component in the management plans for patients requiring ongoing endocrine support.

Improvement in Metabolic Efficiency

Preso aids in optimizing the body’s metabolic efficiency. When hormonal levels are balanced, the body can more effectively process nutrients and manage energy expenditure, which supports general physical well-being and metabolic health.

Eligibility and Restrictions for Use

Official Eligibility Profile for Preso

This section outlines the official eligibility and non-eligibility for Preso, based strictly on regulatory documents from global government health authorities.


Contraindicated Populations (Must Not Use)

Preso is contraindicated and must be avoided in patients with a documented hypersensitivity to the drug or any of its components. Use is also prohibited in patients with certain severe, unstable cardiac arrhythmias or concurrent use of specific strong enzyme inhibitors, if explicitly stated as absolute exclusions in the label.

Age-Related and Condition-Specific Restrictions

Population Group Eligibility Status (Regulatory)
Pediatric Patients Use is not established or contraindicated in children under a specific age (e.g., 12 years) due to insufficient efficacy and safety data.
Pregnancy/Lactation Use is not recommended or prohibited during the third trimester of pregnancy, and breastfeeding should be discontinued due to excretion into human milk.
Severe Organ Impairment Use is restricted or not recommended in patients with severe hepatic (liver) impairment (Child-Pugh Class C) or end-stage renal (kidney) disease.

Eligibility-related restrictions define groups that require special caution or mandatory dose adjustments, such as older adults or patients with moderate organ impairment. These limitations ensure Preso is only used when officially specified conditions are met.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Preso is defined by its role as a CYP enzyme inhibitor and its profound acid-suppressing effect. Formal regulatory documents strictly classify co-administration with Nelfinavir and Rilpivirine-containing products as contraindicated.

Preso's inhibition of the CYP2C19 enzyme results in decreased exposure to the active metabolite of the antiplatelet agent Clopidogrel, leading regulatory bodies to advise avoiding the concomitant use of these medicines. Conversely, this same metabolic inhibition may increase serum concentrations of other drugs, such as the immunosuppressant Tacrolimus and the antineoplastic agent Methotrexate (especially when administered at high doses), requiring consideration for monitoring or temporary withdrawal.

The significant elevation of gastric pH creates a pharmacodynamic interaction that alters the absorption of numerous agents. The absorption of medicines like Ketoconazole, Erlotinib, and Iron Salts is officially stated to be reduced, while the absorption and systemic exposure of Digoxin is increased. Strong enzyme inducers, including Rifampin and the herbal product St. John's Wort, are documented to decrease Esomeprazole serum levels. Procedurally, the intravenous formulation is subject to a timing restriction and must not be administered concomitantly with other medications in the same line. For patients with Severe Hepatic Impairment, the risk of over-exposure to Preso when combined with strong inhibitors necessitates specific regulatory cautions.

Mechanism of Action

How Preso Works

Preso exerts its effect by specifically inhibiting the enzyme Farnesyl Pyrophosphate Synthase (FPPS), a key catalyst within the mevalonate pathway. Preso acts as a competitive inhibitor, binding to the active site of FPPS and thereby blocking the enzymatic formation of farnesyl pyrophosphate. This action leads to a subsequent reduction in the intracellular concentration of the downstream intermediate, geranylgeranyl pyrophosphate (GGPP).

This decrease in GGPP directly limits the process of geranylgeranylation, a critical lipid modification required for the activation and membrane localization of various small GTPase signaling proteins (such as Rho, Rac, and Rab). When geranylgeranylation is impaired, these GTPase proteins remain cytosolic and functionally inactive. The ensuing inactivation disrupts key signal transduction pathways, particularly those governing cytoskeletal organization, cell migration, and certain cell survival processes. This specific molecular intervention modulates overall cellular activity and function.

Dosage and Administration Information

Official Administration Guidelines for Preso

The instructions for using Preso are strictly defined in official documents. These documents establish the mandatory protocol for correct administration.

Administration Scope Official Requirement
Route of Administration Defined by the specific dosage form (e.g., Oral, Intravenous, Subcutaneous).
Dosing Schedule Specifies the exact Initial Dose, Maintenance Dose, and Maximum Daily Dose.
Timing Relative to Meals Requires administration, for example, 'With food,' 'Without regard to meals,' or a specified time before or after a meal.
Preparation Requirements Includes all mandatory steps prior to administration, such as reconstitution of a powder, dilution of a concentrate, or visual inspection of the solution for particulate matter.
Age-Group Rules Contains specific dose adjustments or calculations for defined populations (e.g., pediatric patients, geriatric patients) if they differ from the core adult dose.
Missed-Dose Rules Provides explicit instructions on the course of action if a dose is missed (e.g., take immediately unless near the next dose, or skip the missed dose entirely).

These official instructions, located in the Dosage and Administration section of the product documentation, are essential for consistent and safe use. The precise dose and frequency are mandated to ensure the product is applied as authorized. The protocol also dictates special procedural steps, such as a required infusion rate or pre-treatment medication, which must be followed during administration.

Recent Clinical Evidence

Preso: Recent Clinical Evidence

Overview of Clinical Research

Studies investigated the drug's action on the COX-2 enzyme, and research evaluated the onset of anti-inflammatory effects. The overall body of evidence has focused on the drug's profile in managing various pain and inflammatory conditions.


Efficacy in Pain and Inflammatory Conditions

Multiple randomized controlled trials (RCTs) evaluated whether the drug related to changes in reported chronic low back pain. The majority of studies reported observations of change in symptoms within the first 7 days of treatment initiation. The scope of efficacy research includes evaluation against placebo and other treatments.

For rheumatoid arthritis (RA), research explored whether the combination affected the observed rate of disease progression. These studies typically assessed markers of inflammation and disease activity over periods exceeding one year. Small-scale observational studies have explored the drug's profile in treating acute sports injuries.


Safety and Tolerability Research

The tolerability of the drug was evaluated in clinical trials, which compared its profile to that of older non-selective NSAIDs. Studies examined reported gastrointestinal and cardiovascular events among participants across various indications. Further research is ongoing to evaluate long-term outcomes in specific populations.

Specific Patient Populations

Population Research Focus
Geriatric (aged 65+) Explored tolerance over a three-month period
Liver Issues Clinical trials investigated outcomes for participants with a history of such issues
Pediatric Data remains limited; current efforts focus on evaluating the pharmacokinetic profile in adolescents

Key Studies & References

  1. Persica's antibiotic-based drug alleviates lower back pain in Phase Ib trial (Example of RCT structure/findings for Chronic Back Pain)
  2. Medication-Related Problems in Older Adults (General context for geriatric tolerance/risk)

Frequently Asked Questions (FAQ)

Common questions about Preso (FAQ)


Q: How quickly does Preso start to have an effect?

A: Preso works by irreversibly blocking the proton pump, which is the final step in stomach acid production. Peak concentrations in the blood are typically reached about 1.5 hours following oral administration. Because of how the medicine binds, its strong acid-reducing effect generally lasts for over 24 hours.


Q: Does Preso need to be taken long-term?

A: Regulatory documents indicate that Preso is used for various durations, ranging from short periods, such as a course of 14 days, to longer-term maintenance treatment for certain digestive conditions. The duration of use is determined by the official treatment regimen authorized for the condition being addressed.


Q: Are there any foods or drinks I should avoid while taking Preso?

A: Official administration instructions specify whether Preso should be taken with or without food. While the regulatory label does not generally list common foods to avoid, it does warn against the use of certain herbal products. Regulatory documents state that co-administration with the herbal product St. John's Wort has been associated with decreased levels of Preso.


Q: Is it common to feel tired when starting Preso?

A: The official product safety profile documents side effects based on clinical trial data. While the common reactions are mostly related to the digestive system, other effects listed in the Uncommon category include insomnia (difficulty sleeping) and somnolence (feeling sleepy).


Q: Can older people use Preso?

A: Official regulatory documents state that studies performed have not identified specific problems unique to the elderly that would restrict the use of Preso in older adults. Dose adjustment is generally not necessary for geriatric patients based exclusively on age, according to regulatory guidelines.


Q: Is Preso an addictive medicine?

A: Preso (Esomeprazole) is not classified as a controlled substance by regulatory bodies, such as the FDA. The medicine is not associated with the abuse potential or dependence risks typically seen with controlled (scheduled) medications.


Q: Does the time of day matter when taking Preso?

A: Official instructions specify that Preso is typically a once-daily medicine. The precise administration time may be chosen based on the medical condition being treated or symptom pattern, aiming for consistent acid control.


Q: Are there different strengths of Preso available?

A: Yes, official regulatory approval documents confirm that Preso is available in multiple strengths, which are used for its various dosage forms. For instance, the active ingredient is approved in strengths such as 20 mg and 40 mg capsules.


Q: Why is Preso not suitable for people with a certain medical history?

A: Preso is officially contraindicated (must not be used) in patients who have a known hypersensitivity or severe allergic reaction to the drug itself or to similar medications in its class. Use is also restricted or cautioned against for concurrent use with certain specific strong enzyme inhibitor drugs.


Q: Is Preso a new drug, or has it been around for a while?

A: The active ingredient in Preso, Esomeprazole, has been established for a while. It was initially approved by the U.S. Food and Drug Administration (FDA) in the early 2000s, specifically in February 2001.


Q: Do children or teenagers take Preso?

A: Yes, official regulatory documents describe approved uses for specific conditions in children from 1 year of age and in adolescents (12–17 years of age). Regulatory profiles note that safety and efficacy have not been established for children younger than 1 month of age.


Q: Does Preso affect blood sugar levels?

A: Clinical studies and pharmacological information indicate that Preso alone does not generally cause changes in blood sugar. However, some research has suggested that when co-administered with specific anti-diabetic medications, an interaction profile may exist.


Q: Does Preso affect my ability to drive or operate machinery?

A: The safety profile for Preso notes the potential occurrence of side effects such as dizziness, somnolence (sleepiness), and vertigo (a sensation of spinning). The presence of these effects may influence the ability to drive or operate machinery.


Q: Does Preso interact with common antidepressant medications?

A: Preso is known to affect how certain drugs are processed in the body by interacting with the CYP2C19 enzyme. Regulatory resources list interactions with certain selective serotonin reuptake inhibitors (SSRIs) and other mental health medications, which may require consideration for serum level checks or dose adjustment.


Q: How long does Preso stay in my system after the last dose?

A: The active ingredient, Esomeprazole, is quickly eliminated from the bloodstream, with an elimination half-life of approximately 1 to 1.5 hours. However, the medicine binds irreversibly to the proton pumps, meaning its beneficial acid-suppressing effect continues to work for a full 24 hours or longer.


Q: Is there a generic version of Preso available?

A: Yes, regulatory bodies such as the U.S. FDA have approved and listed generic versions of Esomeprazole magnesium, which is the active ingredient in Preso, for various authorized formulations and strengths.


Q: Are there specific tests needed before starting Preso?

A: The official product label advises that certain tests, such as upper endoscopy, may be required before starting Preso to rule out other serious conditions. This is advised because the use of a proton pump inhibitor may potentially mask the symptoms of underlying serious illnesses.


Q: What happens if I miss a dose of Preso?

A: Official regulatory instructions define a clear protocol for missed doses based on the time elapsed. The protocol specifies whether the missed dose should be taken as soon as it is remembered or whether it should be skipped in favor of the next scheduled dose.


Q: Can Preso be taken with common over-the-counter pain relievers?

A: Official regulatory documents address interactions with specific prescription antiplatelet agents but do not mandate the avoidance of common non-prescription pain relievers. Preso is sometimes used to protect the stomach lining when patients must take non-steroidal anti-inflammatory drugs (NSAIDs) for a specific condition.


Q: Does Preso interact with herbal products or vitamins?

A: Official documentation explicitly mentions that concurrent use of the herbal product St. John's Wort may decrease Preso's levels and should be used with caution. Additionally, regulatory warnings note that long-term use of Preso may potentially interfere with the absorption of Vitamin B-12.


Q: Is Preso safe to use during pregnancy?

A: The official label reports on the use of Preso during pregnancy, noting that data is insufficient to inform a drug-associated risk. Available registry data has not identified a clear risk of major birth defects, miscarriage, or adverse maternal/fetal outcomes.


Q: What about using Preso while breastfeeding?

A: Limited data indicates that the active ingredient is present in low levels in human milk. Regulatory information states that the use of Preso while breastfeeding should be approached cautiously.


Q: Can I take Preso if I have liver problems?

A: Regulatory documents state that use is restricted and a dose adjustment is frequently necessary for patients with severe hepatic (liver) impairment. However, an adjustment is generally not required for those with only mild to moderate liver impairment.


Q: Can I take Preso if I have kidney problems?

A: The official prescribing information indicates that a dose adjustment is generally not required for patients who have renal (kidney) insufficiency. Regulatory documents note that patients with severe renal insufficiency may require a higher degree of consideration due to limited clinical experience in this specific population.


Q: What should I do if I get sick (like a cold or flu) while on Preso?

A: Official warnings note that PPI use, especially over a long period, may be associated with an increased risk of certain infections, such as Clostridium difficile–associated diarrhea (CDAD). Official documents recommend that the drug should be used at the lowest possible dose and for the shortest duration necessary to achieve treatment goals.


Q: Does Preso need to be refrigerated?

A: The standard oral forms of Preso are typically required to be stored at room temperature, away from moisture, heat, and humidity. Only specific, specialized forms, such as the powder intended for injection, may require temporary refrigeration before they are prepared for use.


Q: What are the most common side effects of Preso people talk about?

A: The most commonly reported adverse reactions documented in clinical trials include headache and various gastrointestinal disturbances. These frequently noted digestive effects include abdominal pain, constipation, diarrhea, flatulence, nausea, and vomiting.


Q: What are the main things to avoid when taking Preso?

A: Official regulatory documents explicitly note restrictions regarding the concurrent use of Preso with the antiplatelet agent Clopidogrel, the HIV antiretrovirals Nelfinavir and Rilpivirine-containing products, and the herbal product St. John's Wort.


Q: What is the research evidence for Preso's use?

A: Clinical trials and systematic reviews indicate Preso's effectiveness in providing highly sustained acid suppression, which supports its use in the healing and long-term maintenance treatment of conditions like severe acid reflux (erosive GERD). Studies have also compared its acid control profile with other medicines in its class.


Q: Does Preso treat the cause or just the symptoms?

A: Preso is officially indicated to manage conditions by suppressing the final biological process of acid secretion (addressing a physiological mechanism). This profound acid suppression generally facilitates the alleviation of symptoms (like heartburn) and provides a physiological environment supportive of tissue healing.


Q: Are there any serious side effects of Preso I should be aware of?

A: Regulatory documents describe certain serious, though infrequent, risks associated with use. These include a potential increased risk of bone fractures of the hip, wrist, or spine with long-term therapy, the possibility of low serum magnesium (hypomagnesemia), and severe, rare dermatological reactions.

How should Preso be stored and disposed of?

Preso should be stored securely in its original container at room temperature, away from direct light, heat, and moisture. Keep all medications out of the reach of children and pets to prevent accidental ingestion. Do not store this drug in a bathroom or other high-humidity area unless the product labeling explicitly instructs otherwise.

Disposal Guidelines

Disposal Method Guidance
Best Option Return unused or expired Preso to a community pharmacy or an authorized national drug take-back program (e.g., local collection events or drop-off sites). This is the safest way to ensure proper environmental handling.
Household Trash If a take-back option is unavailable, and the drug is not on a special “flush list,” mix it with an undesirable substance like dirt, cat litter, or used coffee grounds. Place this mixture in a sealed bag or container to prevent leakage, then discard it in the household trash.
Flushing Only flush down the toilet if specific product labeling or an official regulatory flush list instructs you to do so, as this action is typically reserved for drugs with a high risk of accidental ingestion and harm.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Preso found in:

A-Z Index: